Oppenheimer & Co. Inc. lessened its holdings in shares of Huntsman Co. (NYSE:HUN – Free Report) by 1.6% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 89,553 shares of the basic materials company’s stock after selling 1,451 shares during the period. Oppenheimer & Co. Inc. owned about 0.05% of Huntsman worth $2,167,000 at the end of the most recent quarter.
Other institutional investors have also made changes to their positions in the company. Diversified Trust Co acquired a new position in Huntsman in the 2nd quarter valued at $2,180,000. Acadian Asset Management LLC lifted its position in Huntsman by 1,052.7% during the first quarter. Acadian Asset Management LLC now owns 209,442 shares of the basic materials company’s stock worth $5,449,000 after purchasing an additional 191,272 shares during the period. 1832 Asset Management L.P. grew its stake in Huntsman by 753.2% during the first quarter. 1832 Asset Management L.P. now owns 2,867,920 shares of the basic materials company’s stock worth $74,652,000 after buying an additional 2,531,800 shares in the last quarter. AQR Capital Management LLC increased its holdings in Huntsman by 383.0% in the 2nd quarter. AQR Capital Management LLC now owns 1,417,641 shares of the basic materials company’s stock valued at $32,138,000 after buying an additional 1,124,113 shares during the period. Finally, Boston Partners acquired a new position in shares of Huntsman in the 1st quarter valued at approximately $793,000. 84.81% of the stock is currently owned by institutional investors.
Insider Activity at Huntsman
In other Huntsman news, Director Mary C. Beckerle sold 20,201 shares of the company’s stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $21.42, for a total value of $432,705.42. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 5.60% of the stock is currently owned by company insiders.
Wall Street Analysts Forecast Growth
Check Out Our Latest Analysis on Huntsman
Huntsman Price Performance
Huntsman stock opened at $19.55 on Friday. The stock has a 50-day moving average price of $22.46 and a two-hundred day moving average price of $22.84. Huntsman Co. has a 12 month low of $19.14 and a 12 month high of $27.01. The company has a market capitalization of $3.38 billion, a PE ratio of -28.33 and a beta of 1.02. The company has a current ratio of 1.47, a quick ratio of 0.83 and a debt-to-equity ratio of 0.45.
Huntsman (NYSE:HUN – Get Free Report) last issued its quarterly earnings data on Monday, November 4th. The basic materials company reported $0.10 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.10. Huntsman had a negative net margin of 1.99% and a negative return on equity of 0.03%. The business had revenue of $1.54 billion during the quarter, compared to analyst estimates of $1.55 billion. During the same quarter last year, the business earned $0.15 EPS. The firm’s quarterly revenue was up 2.3% on a year-over-year basis. Analysts expect that Huntsman Co. will post 0.11 EPS for the current year.
Huntsman Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 31st. Investors of record on Friday, December 13th will be paid a $0.25 dividend. The ex-dividend date of this dividend is Friday, December 13th. This represents a $1.00 annualized dividend and a dividend yield of 5.12%. Huntsman’s dividend payout ratio is -144.93%.
Huntsman Company Profile
Huntsman Corporation manufactures and sells diversified organic chemical products worldwide. The company operates in three segments: Polyurethanes, Performance Products, and Advanced Materials. The Polyurethanes segment offers polyurethane chemicals, including methyl diphenyl diisocyanate, polyether and polyester polyols, and thermoplastic polyurethane; and aniline, benzene, nitrobenzene and other co-products.
Further Reading
- Five stocks we like better than Huntsman
- Low PE Growth Stocks: Unlocking Investment Opportunities
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- Investing in the High PE Growth Stocks
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Find and Profitably Trade Stocks at 52-Week Lows
- Time to Load Up on Home Builders?
Receive News & Ratings for Huntsman Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Huntsman and related companies with MarketBeat.com's FREE daily email newsletter.